Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Atlas Venture Life Science Advisors, LLC
Form 13F · Q2 2026

Atlas Venture Life Science Advisors, LLC

CIK 1917529Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$881M
Reported book value
7
Positions
12
Quarters on record
Top 50
Positions

Atlas Venture Life Science Advisors, LLC — holdings

Top 7 positions of 7, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1KYMR Kymera Therapeutics Inc2.8M−37.8%$327M37.1%
2DYN Dyne Therapeutics Inc6.8M−25.5%$151M17.1%
3SION Sionna Therapeutics Inc3.0M+0.0%$132M15.0%
4KLRA Kailera Therapeutics Inc5.2M—$114M12.9%
5IRON Disc Medicine Inc1.5M+0.0%$111M12.6%
6QTTB Q32 Bio Inc2.7M+29.9%$35M3.9%
7KRRO Korro Bio Inc962,884−15.3%$13M1.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.